Fact CheckerSign in

NCT01719016Active, not recruiting

Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics

Source: ClinicalTrials.gov · Last updated 4 Sept 2026

Brief summary (registry, in English)

Diagnosis of relative contributions of large artery blockages and microvascular blockages is very much needed in the treatment of coronary artery disease. In order to achieve this, two novel parameters, pressure drop coefficient (CDP), which combines flow and pressure readings and Lesion flow coefficient (LFC), which combines anatomical details of the lesion with pressure and flow readings, are being investigated.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
68 (actual)
First submitted
29 Oct 2012
Start date
Aug 2010
Primary completion date
Jul 2027
Lead sponsor
University of Cincinnati
NCT number
NCT01719016

What you commit to

  • Study type: Observational
  • Participants enrolled: 68
  • From Aug 2010 to the primary completion date, Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of type II heparin-induced thrombocytopenia.
  • Significant co-morbid condition that is medically unstable and would make coronary angiography prohibitive or contraindicated.

Lab values

  • Left ventricular ejection fraction less the 25% determined by gated SPECT imaging
  • Non-dialysis dependent chronic kidney disease with baseline serum creatinine greater than 2.5 gm/dL.

Other

  • Pregnant women.
  • Incapacitated for Consent

Who the study is looking for

  • 18 years of age or above
  • Patients referred to a stress test by a Cardiologist
  • Acute Chest pain, as per patient input.
  • Risk Assessment with prior test results and/or previous history of known chronic stable CAD.
  • Borderline or discordant stress testing where obstructive CAD remains a concern.
  • New or worsening symptoms- Abnormal coronary angiography or abnormal prior stress imaging study.
  • Coronary stenosis or anatomic abnormality of uncertain significance.
  • In absence of reliable diagnostic information from another imaging modality.

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cincinnati Veteran Affairs Medical Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.